Summary
Biogen Idec Inc. (BIIB) filed an 8-K on April 21, 2011, primarily to furnish a press release detailing its financial results for the three months ended March 31, 2011. This filing is crucial for investors seeking to understand the company's recent performance and financial standing. The press release, attached as Exhibit 99, contains the operational and financial data for the first quarter of 2011. While the 8-K itself does not disclose the specific financial figures, it directs investors to the furnished press release for details on revenue, profitability, and other key performance indicators. This is a standard practice for announcing quarterly earnings, allowing for a more comprehensive and immediate dissemination of financial information to the market. Investors should review Exhibit 99 for the actual financial results and any management commentary provided therein.
Key Highlights
- 1Biogen Idec announced its Q1 2011 financial results via a press release.
- 2The press release is furnished as Exhibit 99 to the 8-K filing.
- 3The filing serves as notification to the market of the company's financial performance for the quarter ended March 31, 2011.
- 4Information on operations and financial condition for the period is contained within the press release.
- 5The press release is not deemed 'filed' under Section 18 of the Exchange Act, limiting its liability exposure.
- 6This filing is a procedural step to incorporate the earnings release into public record.